Allergy medications that may cause diarrhoea include several commonly prescribed treatments, though this side effect occurs less frequently than other gastrointestinal symptoms. Antihistamines such as cetirizine and loratadine, leukotriene receptor antagonists like montelukast, and oral mast cell stabilisers can occasionally affect bowel function. Whilst most cases are mild and self-limiting, understanding which allergy medications carry this risk—and how to manage symptoms effectively—helps patients maintain both allergy control and digestive comfort. This article examines the specific medications associated with diarrhoea, the mechanisms involved, and practical strategies for managing this side effect whilst continuing effective allergy treatment.

Understanding Diarrhoea as a Side Effect of Allergy Medications

Diarrhoea—defined as passing three or more loose or watery stools per day—is recognised as a potential adverse effect of various allergy medications, though it occurs less frequently than other gastrointestinal symptoms such as nausea or abdominal discomfort. When taking medications for allergic rhinitis, urticaria, or other allergic conditions, it is important to understand that whilst these treatments effectively manage allergic symptoms, they may occasionally affect the digestive system.

The incidence of diarrhoea varies considerably depending on the specific medication, dosage, formulation, and individual patient factors. According to the Summary of Product Characteristics (SmPC) for individual medicines available via the electronic medicines compendium (emc), gastrointestinal disturbances are documented side effects for several classes of allergy medications, though they typically affect only a small proportion of users. Most cases are mild and self-limiting, resolving either spontaneously or upon discontinuation of the medication.

Key points to consider:

• Diarrhoea may develop shortly after starting a new allergy medication or following a dose increase

• The severity can range from mild loose stools to more frequent bowel movements

• Individual susceptibility varies based on factors including age, concurrent medications, and underlying health conditions

• The frequency of diarrhoea differs by medicine and is described using standard categories (common, uncommon, rare) in the SmPC for each product

It is essential to distinguish between medication-related diarrhoea and other potential causes, such as viral gastroenteritis, food intolerance, or underlying gastrointestinal conditions. Keeping a symptom diary noting when diarrhoea began in relation to starting or changing allergy medications can help healthcare professionals determine whether there is a genuine association. Patients should never abruptly discontinue prescribed medications without consulting their GP or pharmacist, as this may lead to inadequate control of allergic symptoms.

Common Allergy Medications That May Cause Diarrhoea

Several categories of allergy medications have been associated with diarrhoea as a documented adverse effect, though the frequency and severity vary between drug classes and individual preparations.

Antihistamines are the most commonly used allergy medications and are generally well-tolerated. Second-generation antihistamines such as cetirizine, loratadine, and fexofenadine may cause gastrointestinal disturbances in some individuals. According to the SmPC for cetirizine, diarrhoea is listed as an adverse reaction, with frequency varying by age group—it is reported as common (up to 1 in 10) in paediatric populations and less frequent in adults. Loratadine and fexofenadine also list gastrointestinal effects including diarrhoea, though these are generally uncommon.

Leukotriene receptor antagonists, notably montelukast, are prescribed for allergic rhinitis and asthma. According to the SmPC and the British National Formulary (BNF), diarrhoea is reported as common (affecting up to 1 in 10 people) particularly in paediatric clinical trials; the frequency in adults may differ. This medication works by blocking inflammatory mediators involved in allergic responses.

Mast cell stabilisers such as sodium cromoglicate (Nalcrom), when taken orally for food allergies, may cause diarrhoea as the medication acts locally in the gut. This is particularly relevant for oral preparations rather than nasal or inhaled formulations, which have minimal systemic gastrointestinal effects. The SmPC for Nalcrom lists diarrhoea among the gastrointestinal adverse reactions.

Corticosteroids, including oral prednisolone prescribed for severe allergic reactions, may occasionally cause gastrointestinal disturbances such as dyspepsia. Diarrhoea is not a typical adverse effect of short-course corticosteroids, though gastrointestinal symptoms can occur.

Combination preparations containing multiple active ingredients carry the adverse-effect profile of each component. Decongestants such as pseudoephedrine, often combined with antihistamines in over-the-counter allergy medications, may occasionally cause gastrointestinal symptoms; the overall risk reflects the individual ingredients rather than a synergistic effect.

Intranasal corticosteroids and antihistamine nasal sprays or ophthalmic preparations have minimal systemic absorption and are unlikely to cause gastrointestinal side effects, making them useful alternatives for patients experiencing such issues with oral medications.

Why Some Antihistamines and Allergy Treatments Affect Digestion

The mechanisms by which allergy medications may cause diarrhoea are multifaceted and relate to both the pharmacological actions of these drugs and their effects on gastrointestinal physiology.

Histamine receptor activity in the gut plays a role in digestive function. Antihistamines primarily target H1 receptors to reduce allergic symptoms such as itching, sneezing, and hives. Histamine receptors are also present throughout the gastrointestinal tract; however, it is important to note that gastric acid secretion is primarily regulated by H2 receptors (not H1), which are not the target of standard allergy antihistamines. The exact mechanisms by which H1 antihistamines may occasionally cause diarrhoea are not fully understood, though alterations in gut motility or secretion may play a role in susceptible individuals.

Direct irritation of the gastrointestinal mucosa may occur with certain formulations, particularly when medications are taken on an empty stomach, though this is not typical for most oral antihistamines. The excipients and inactive ingredients in tablets or capsules may also contribute to gastrointestinal upset in sensitive individuals.

Osmotic effects may occur with liquid formulations containing sorbitol or other sugar alcohols as sweetening agents. These substances can draw water into the intestinal lumen, resulting in loose stools or diarrhoea, especially when consumed in larger quantities. Patients experiencing diarrhoea with liquid preparations may benefit from checking the label for sorbitol or other sugar alcohols and considering a switch to tablet formulations or sorbitol-free alternatives.

Leukotriene pathway modulation by medications such as montelukast affects inflammatory mediators involved in allergic and asthmatic responses. Whilst the precise mechanism linking montelukast to diarrhoea is not fully established, gastrointestinal adverse effects are documented in clinical trials, particularly in paediatric populations.

It is important to recognise that for many allergy medications, the exact pathways leading to diarrhoea in some individuals remain incompletely understood, and further research continues to clarify these mechanisms.

Managing Diarrhoea While Taking Allergy Medications

Effective management of medication-related diarrhoea requires a balanced approach that maintains adequate allergy control whilst minimising gastrointestinal symptoms.

Timing and administration modifications can significantly reduce gastrointestinal side effects. Taking allergy medications with food rather than on an empty stomach may decrease irritation to the gastric and intestinal lining for some preparations. Always follow the specific instructions provided with your medication, as some preparations require particular timing for optimal absorption. For example, fexofenadine should be taken with water and not with fruit juices (such as grapefruit, orange, or apple juice), as these can reduce the medicine's absorption and effectiveness.

Hydration and dietary adjustments are essential when experiencing diarrhoea. Maintain adequate fluid intake to prevent dehydration, particularly important for older adults, young children, and those taking diuretics. The NHS recommends drinking small amounts frequently rather than large volumes at once. Oral rehydration salts (ORS), available from pharmacies, are recommended to replace lost fluids and electrolytes, especially if diarrhoea is frequent or prolonged. A bland diet avoiding fatty, spicy, or high-fibre foods may help settle the digestive system. Probiotic supplements or probiotic-rich foods such as live yoghurt may help restore gut microbiome balance, though evidence for their effectiveness in medication-related diarrhoea is limited.

Checking formulations is worthwhile if diarrhoea develops. Liquid medicines may contain sorbitol or other sugar alcohols that can cause osmotic diarrhoea; switching to tablet or capsule forms may resolve the issue. Discuss this with your pharmacist.

Medication review with healthcare professionals is crucial if diarrhoea persists beyond a few days. Your GP or pharmacist may suggest:

• Switching to an alternative antihistamine with a different side-effect profile

• Adjusting the dosage if clinically appropriate

• Changing the formulation (e.g., from liquid to tablet)

• Considering intranasal corticosteroids or antihistamine nasal sprays, which have minimal systemic gastrointestinal effects

• Temporarily using a different class of allergy medication

Symptomatic treatment with anti-diarrhoeal medications such as loperamide may provide short-term relief, but should only be used after consulting a pharmacist or GP. According to the BNF and NHS guidance, loperamide is not suitable for children under 12 years without medical advice, and should be avoided in pregnancy unless advised by a doctor, in acute ulcerative colitis, if there is blood in the stool, or if infection with Clostridioides difficile is suspected. Never combine multiple treatments without professional advice, as drug interactions may occur.

When to Seek Medical Advice About Medication Side Effects

Whilst mild diarrhoea may resolve spontaneously or with simple measures, certain situations require prompt medical assessment to ensure patient safety and appropriate management.

Call 999 or go to A&E immediately if you experience:

• Symptoms of a severe allergic reaction (anaphylaxis) to the medication itself, such as difficulty breathing, swelling of the lips, tongue, or throat, sudden wheeze, or collapse

• Severe abdominal pain that is worsening or persistent

• Signs of severe dehydration including confusion, reduced urination, extreme thirst, or dizziness on standing

Contact 111 or your GP urgently if you experience:

• Severe or bloody diarrhoea, which may indicate serious gastrointestinal pathology

• High fever (above 38°C) accompanying diarrhoea, suggesting possible infection

• Diarrhoea lasting more than 2 days in babies or young children, or more than 7 days in adults (seek help sooner if other concerning symptoms are present)

• Signs of dehydration that are worsening despite oral rehydration measures

Contact your GP or pharmacist for routine advice if:

• Diarrhoea is persistent but mild, continuing beyond a few days despite simple measures

• You are uncertain whether your symptoms are related to your allergy medication

• You wish to discuss alternative treatment options for your allergic condition

• You are taking multiple medications and are concerned about potential interactions

• You have underlying health conditions such as inflammatory bowel disease, diabetes, or kidney problems that may be affected by diarrhoea

Special considerations apply to vulnerable groups. Older adults, young children, pregnant women, and individuals with compromised immune systems should seek medical advice earlier, as they are at higher risk of complications from diarrhoea and dehydration. According to NICE guidance (NG12), any significant unexplained change in bowel habit lasting more than 6 weeks in adults aged 60 years or over warrants clinical assessment and consideration of referral to exclude colorectal cancer.

Reporting adverse effects to the Medicines and Healthcare products Regulatory Agency (MHRA) through the Yellow Card Scheme (https://yellowcard.mhra.gov.uk) helps monitor medication safety. Even if you are unsure whether diarrhoea is related to your allergy medication, reporting suspected side effects contributes to ongoing pharmacovigilance and helps protect other patients. Healthcare professionals can assist with completing Yellow Card reports during consultations.

Frequently Asked Questions